Retningslinjer

SNO (Society for NeuroOncology)

​

SNO Guidelines Endorsement

​

Primære CNS-svulster

• Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions (Neuro-Oncology, 2022)

 

• Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline (Pract Radiat Oncol 2022)

​

• EANO, EURACAN, SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors (Neuro Oncol. 2022)

​

• Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults:  ASCO-SNO Guidelines (J Clin Oncol. 2022)

​

• EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults (Neuro Oncol. 2022)

​

• SNO/EANO consensus review Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions (Neuro Oncol. 2020)

​

​

Cerebrale og meningeale metastaser

• Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline (J Clin Oncol. 2022)

​

• Radiation Therapy for Brain Metastases Guideline (Pract Radiat Oncol. 2022)

​

• Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions (Neuro-Oncology, 2022)

​

Støttebehandling og palliativ behandling

• SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors (Neuro Oncol. 2021)

​

Bildediagnostikk

• Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas (Neuro Oncol. 2020)

​

ASCO

ASCO (American Society of Clinical Oncology)

• Neurooncology

​

• Supportive care and treatment related issues

​

• Patient and survivor care

​

​